Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study
Open Access
- 7 October 2023
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 40, 100928
Abstract
No abstract availableKeywords
Funding Information
- World Health Organization
- Australian Research Data Commons
- Wellcome Trust
- World Cancer Research Fund
- Australian Research Council
- National Health and Medical Research Council
- Department of Health and Aged Care, Australian Government
This publication has 16 references indexed in Scilit:
- Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control studyEmerging Microbes & Infections, 2022
- Duration of effectiveness of vaccination against COVID-19 caused by the omicron variantThe Lancet Infectious Diseases, 2022
- Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health OrganizationVaccine, 2022
- Effectiveness of Messenger RNA–based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron VariantClinical Infectious Diseases, 2022
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regressionThe Lancet, 2022
- Long-term cardiovascular outcomes of COVID-19Nature Medicine, 2022
- Effectiveness of Covid-19 Vaccines over a 9-Month Period in North CarolinaNew England Journal of Medicine, 2022
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature, 2022
- High risk groups for severe COVID-19 in a whole of population cohort in AustraliaBMC Infectious Diseases, 2021
- The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification SystemBMJ Open, 2018